Delhi, March 17, 2025 (GLOBE NEWSWIRE) -- Global Transdermal Patch Market Opportunity, Patch Dosage, Price & Clinical Trials Insight 2030 Report Highlights & Findings: The global market for ...

United States The type of adhesive patches known as transdermal patches is therapeutic. By utilizing transdermal technology and the diffusion technique, they assist in delivering a predetermined dose ...

Nutriband Inc. today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica for AVERSA Fentanyl upon approval and all sports tape products manufactured at ...

This article was reviewed by Julia Switzer, MD, FACOG. Key Takeaways Estrogen gels and patches are both effective HRT options for easing menopause symptoms like hot … ...

The transdermal patches market is further segmented based on the patch type, adhesive type, application, distribution channel, end-user, and region. The Drug-In-Adhesives segment is expected to ...

Zeus Hygia Lifesciences and Patch House Labs to develop transdermal delivery systems for premium nutraceutical ingredients: Our Bureau, Bengaluru Friday, February 20, 2026, 15:30 ...

CHICAGO, IL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional ...

Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...

Restless legs syndrome (RLS) is a chronic, usually idiopathic disorder characterized by uncontrollable urges to move the legs or arms at night along with unpleasant sensations in the affected limbs.

NEW YORK, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical or dermatological advice. Always consult a qualified ...

The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.